HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Chung Jiang Selected Research

Cellular Apoptosis Susceptibility Protein

10/2016CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
1/2015High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
12/2012CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
10/2012Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
4/2010Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.
1/2010Presence of secretory cellular apoptosis susceptibility protein in cerebrospinal fluids of patients with intracerebral hemorrhage caused by stroke and neurotrauma.
5/2009Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer.
7/2008CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
3/2008CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Chung Jiang Research Topics

Disease

18Neoplasms (Cancer)
10/2016 - 03/2005
7Melanoma (Melanoma, Malignant)
11/2016 - 05/2009
7Neoplasm Metastasis (Metastasis)
10/2016 - 07/2008
4Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 04/2010
2Colonic Neoplasms (Colon Cancer)
06/2015 - 08/2009
2Breast Neoplasms (Breast Cancer)
10/2013 - 10/2010
2Carcinoma (Carcinomatosis)
10/2013 - 10/2012
1Adenocarcinoma
10/2014
1Adenoma (Adenomas)
10/2014
1Stroke (Strokes)
01/2010
1Cerebral Hemorrhage
01/2010

Drug/Important Bio-Agent (IBA)

9Cellular Apoptosis Susceptibility ProteinIBA
10/2016 - 03/2008
7Proteins (Proteins, Gene)FDA Link
10/2016 - 01/2008
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2013 - 12/2012
2Microphthalmia-Associated Transcription FactorIBA
11/2016 - 10/2016
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
11/2016 - 10/2016
2Small Interfering RNA (siRNA)IBA
11/2016 - 09/2013
2Biomarkers (Surrogate Marker)IBA
10/2016 - 10/2013
2Pharmaceutical PreparationsIBA
06/2015 - 08/2010
2Growth Factor ReceptorsIBA
06/2015 - 10/2014
2Matrix Metalloproteinases (MMPs)IBA
12/2012 - 08/2009
2Peptide Hydrolases (Proteases)FDA Link
12/2012 - 07/2008
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2010 - 03/2008
2Cisplatin (Platino)FDA LinkGeneric
03/2008 - 01/2008
2Fluorouracil (Carac)FDA LinkGeneric
03/2008 - 01/2008
2TamoxifenFDA LinkGeneric
03/2008 - 01/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 01/2008
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2016
1Protein Kinases (Protein Kinase)IBA
11/2016
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
11/2016
1Immunoconjugates (Immunoconjugate)IBA
10/2016
1Indicators and Reagents (Reagents)IBA
10/2016
1Sunitinib (Sutent)FDA Link
06/2015
1VemurafenibIBA
06/2015
1Lapatinib (GW572016)FDA Link
06/2015
1Phosphotransferases (Kinase)IBA
06/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2015
1Mitogen-Activated Protein Kinase 3IBA
01/2015
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2012
1TubulinIBA
10/2010
1Carcinoembryonic AntigenIBA
04/2010
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2009
1GelatinIBA
08/2009
1Prostaglandins FIBA
08/2009
1ProstaglandinsIBA
08/2009
1Conditioned Culture MediaIBA
05/2009
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2008
1matrigelIBA
07/2008
1Paclitaxel (Taxol)FDA LinkGeneric
03/2008
1DNA (Deoxyribonucleic Acid)IBA
03/2005

Therapy/Procedure

3Therapeutics
10/2016 - 12/2012
3Drug Therapy (Chemotherapy)
08/2010 - 01/2008
1Quantum Dots (Quantum Dot)
12/2012